These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7541570)

  • 1. [Radiotherapy in prostatic carcinoma].
    Huguenin P; Lütolf UM
    Ther Umsch; 1995 Jun; 52(6):411-7. PubMed ID: 7541570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-D conformal radiotherapy for prostate cancer. The University of Michigan experience.
    Sandler HM
    Front Radiat Ther Oncol; 1996; 29():238-43. PubMed ID: 8742904
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate cancer treatment with radiotherapy: maturing methods that minimize morbidity.
    Pollack A; Zagars GK; Rosen II
    Semin Oncol; 1999 Apr; 26(2):150-61. PubMed ID: 10597726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute side effects during 3-D-planned conformal radiotherapy of prostate cancer. Differences between patient's self-reported questionnaire and the corresponding doctor's report.
    Goldner G; Wachter-Gerstner N; Wachter S; Dieckmann K; Janda M; Pötter R
    Strahlenther Onkol; 2003 May; 179(5):320-7. PubMed ID: 12740659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
    Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB
    Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
    Luxton G; Hancock SL; Boyer AL
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Initial results of three-dimensional planned irradiation of prostate carcinoma. Irradiation technique and toxicity].
    Wiegel T; Schmidt R; Baumann M; Schwarz R; Steiner P; Arps H; Göckel-Beining B
    Rontgenpraxis; 1994 Nov; 47(11):334-7. PubMed ID: 7825071
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer.
    Hiratsuka J; Jo Y; Yoshida K; Nagase N; Fujisawa M; Imajo Y
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):684-90. PubMed ID: 15183471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
    Brabbins D; Martinez A; Yan D; Lockman D; Wallace M; Gustafson G; Chen P; Vicini F; Wong J
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):400-8. PubMed ID: 15667959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute toxicity of curative radiotherapy in elderly patients.
    Huguenin P; Glanzmann C; Lütolf UM
    Strahlenther Onkol; 1996 Dec; 172(12):658-63. PubMed ID: 8972750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy combined with hormonal therapy (RT-HT) in prostate cancer patients with low, intermediate, and high risk of biochemical recurrence: perspective and therapeutic gain analysis.
    Milecki P; Kwias Z; Martenka DJ
    Neoplasma; 2007; 54(1):7-15. PubMed ID: 17203887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Constraints and dosage for prostate cancer patients treated with conformal radiotherapy and intensity modulated radiation therapy].
    Chauvet I; Gaboriaud G; Pontvert D; Zefkili S; Giraud P; Rosenwald JC; Cosset JM
    Cancer Radiother; 2004 Dec; 8(6):337-51. PubMed ID: 15619378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing the toxicity associated with the use of radiotherapy in men with localized prostate cancer.
    Roach M
    Urol Clin North Am; 2004 May; 31(2):353-66. PubMed ID: 15123413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When should the seminal vesicles be included in the target volume in prostate radiotherapy?
    Bayman NA; Wylie JP
    Clin Oncol (R Coll Radiol); 2007 Jun; 19(5):302-7. PubMed ID: 17448647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio.
    Hille A; Töws N; Schmidberger H; Hess CF
    Strahlenther Onkol; 2005 Dec; 181(12):789-95. PubMed ID: 16362789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal toxicity with 3-FAT radiotherapy of prostate cancer.
    Weil MD; Crawford ED; Cornish P; Dzingle W; Stuhr K; Pickett B; Roach M
    Semin Urol Oncol; 2000 May; 18(2):127-32. PubMed ID: 10875453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity-modulated radiation therapy for prostate cancer.
    Zelefsky MJ; Fuks Z; Leibel SA
    Semin Radiat Oncol; 2002 Jul; 12(3):229-37. PubMed ID: 12118388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer.
    Fonteyne V; De Gersem W; De Neve W; Jacobs F; Lumen N; Vandecasteele K; Villeirs G; De Meerleer G
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1013-20. PubMed ID: 19386427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.
    Das IJ; Cheng CW; Chopra KL; Mitra RK; Srivastava SP; Glatstein E
    J Natl Cancer Inst; 2008 Mar; 100(5):300-7. PubMed ID: 18314476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.